In Section A, contributors will receive unique doses and schedules of oral ABBV-744 pill to detect Protected dosing routine. Additional individuals are going to be enrolled on the determined monotherapy dosign regimen. In Section B, contributors will acquire oral ruxolitinib and ABBV-744 will probably be specified as "include-on" therapy. In https://abbv-744-for-small-cell-l24578.is-blog.com/38346061/the-2-minute-rule-for-abbv-744-in-the-treatment-of-drug-resistant-cancers